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A 24-year-old women presented with unresolved right upper lobe consolidation. Her medical history
was notable for asthma, coronary artery disease, cerebrovascular accident, and nasal polyposis. Thoracic
computed tomography scan revealed total atelectasis in the right upper and middle lobes, and consol-
idation in the atelectatic regions. A bronchial mucosal biopsy revealed diffuse eosinophilic inﬁltrates in
the interstitium. Clinical presentation and pathological results of bronchoscopy were consistent with
Churg–Strauss syndrome. In Churg–Strauss syndrome, radiologic pulmonary manifestations vary and
atelectasis is very rare. In this case, mechanism of the lobar atelectasis might be explained by eosino-
philic inﬁltration of airway walls resulting in airway narrowing.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Churg–Strauss syndrome was ﬁrst described in 1951 as a path-
ological syndrome of allergic granulomatosis and angiitis. It was
deﬁned during the 1994 International Consensus Conference as an
eosinophil-rich and granulomatous inﬂammation involving the
respiratory tract with necrotizing vasculitis affecting small-to-
medium-sized vessels and associated with asthma and eosino-
philia.1,2 Here we reported a rare radiological manifestation of
Churg–Strauss syndrome.2. Case report
A 24-year-old women presented to the emergency department
of our hospital with a 2-week history of fever and cough. On chest
radiographs, a nonhomogeneous density in the right upper zone of
the lung was seen (Fig. 1). The diagnosis was pneumonia, and the
patient was prescribed levoﬂoxacin (500 mg/day) for 14 days.
Follow-up examination at 2 weeks revealed an oxygen saturation
level which was 95% while breathing room air. Results of a physical
examination were remarkable for bilateral diffuse rhonchi, and
diminished breath sounds on the anterior surface of the right chest
wall with dullness to percussion were evident. She had a moveable
soft mass (9 cm) on her left tibia. Findings on chest radiographDepartment of Pulmonary
ler, Ankara, Turkey. Tel.: þ90
li).showed no improvement. The patient was hospitalized to deter-
mine the etiology of the atelectasis, and a differential diagnosis of
tuberculosis, unresolved pneumonia, vasculitis, allergic broncho-
pulmonary aspergillosis, hypersensitivity pneumonitis, and foreign
body aspiration was given.
Asthma had been diagnosed in the patient 5 years earlier owing
to occasional wheezing, and inhaled budesonide (160 mg) and for-
moterol (4.5 mg) were prescribed; oral montelukast (10 mg tablet)
was added to the regimen last year. On pulmonary function testing,
the patient had reversible airﬂow obstruction. She also had been
treated for nasal polyposis with nasal polypectomy 6 months
earlier. Her history was notable for anteroseptal myocardial
infarction and a cerebrovascular accident in 2003. Cranial magnetic
resonance imaging (MRI) at that time demonstrated an acute/
subacute infarct at the superior right cerebellar hemisphere and
medial temporal lobe. She had no history of other lung diseases,
tobacco use, recent travel, change in her home environment, or
a new pet.
On admission, her white blood cell count was 12,400 per cubic
millimeter with 70% polymorphonuclear lymphocytes and 12%
eosinophils. The erythrocyte sedimentation rate was 38 mm/hour
and C-reactive protein was 56 mg/dL. Thoracic computed tomog-
raphy (CT) scan revealed total atelectasis in the right upper and
middle lobes, consolidation in the atelectatic regions, narrowing in
the bronchi of the right upper and middle lobes, several small
mediastinal and bilateral hilar lymph nodes, and compensatory
hyperaeration of the right lower lobe and the left upper lobe; there
was no evidence of pulmonary thromboembolism (Fig. 2)
Total eosinophil count and IgE were elevated. Results of a urine
analysis were negative for blood and protein. An echocardiogram
Fig. 1. PA-right sided chest radiography.
Fig. 2. Thorax CT: Total atelectasis in right upper and medium lobes, consolidation in atelectatic regions, bronchial narrowing in right upper and medium lobes’ bronchi, several
small mediastinal and bilateral hilar lymph nodes and compensatory hyperaeration of right lower lobe and left upper lobe; no evidence of pulmonary thromboembolism.
Fig. 3. Cranial MRI: Defective changes in bilateral maxillary sinus medial wall and medium concha secondary to surgery, diffuse mucosal thickness and nasal polyposis in paranasal
sinuses.
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Fig. 4. Fiberoptic Bronchoscopy: Concentrically narrowed bronchi in the right upper and middle lobes; medial and lateral segments of middle lobe not seen.
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tricular thrombi. Tests for antineutrophil cytoplasmic antibodies
(ANCA), antinuclear antibody (ANA), rheumatoid factor (RF), anti-
double-stranded DNA (anti ds-DNA), anti-Ro/SSA, anti-La/SSB, Scl
70, and indirect Coombs test results were negative. Anti-cardiolipin
IgG and IgM levels were normal. Results of serologic tests for
aspergillus-speciﬁc antibodies were negative. Cranial MRI and
diffusion MRI revealed defective changes in the bilateral maxillary
sinus medial walls and the medial concha secondary to surgery,
diffuse mucosal thickening and nasal polyposis in the paranasal
sinuses, cystic encephalomalacia in the superior right cerebellar
hemisphere, and minimal gliosis around the cystic encephaloma-
lacia (Fig. 3).
A lower-extremity MRI revealed a 9 3,5 2 cm solid mass on
the anterior surface of the left tibia. An excisional biopsy of the mass
was performed demonstrating a lipoma. The patient had no elec-
tromyographic evidence of neuropathy. A bronchoscopy revealed
that the bronchi in the right upper and middle lobes were concen-
trically narrowed; the medial and lateral segments of the middle
lobe were not seen (Fig. 4). Samples from a bronchoalveolar lavage
were negative for acid-fast bacilli, and bacteriological cultures were
sterile. The bronchoalveolar lavage ﬂuid contained 78% eosinophils,Fig. 5. Bronchial mucosal biopsy: Diffuse eosinophilic inﬁltrates in interstitium and
thickness in basal membrane.and results of a mucosal biopsy showed diffuse eosinophilic inﬁl-
trates in the interstitium and thickening in the basal membrane
(Fig. 5). The patient’s presentation and results of the bronchoscopy
were consistent with Churg–Strauss syndrome. Montelukast was
discontinued, and treatment with methyl prednisolone (80 mg/day)
was initiated, and the dose has been tapering. One-month control
thoracic CT revealed ﬁbrotic sequela in the middle lobe of the right
lung and improvement of the atelectasis (Fig. 6).
3. Discussion
The patient’s symptoms, the ﬁndings on physical examination,
and eosinophilia were consistent with presence of asthma.
However, the atelectasis and elevated diaphragm evident on radi-
ography, as well as the elevated sedimentation rates were not
consistent with asthma. Another possible diagnosis might have
been allergic bronchopulmonary aspergillosis, but the results of
a serologic test for aspergillus-speciﬁc antibodies were negative,
and a thoracic CT scan did not reveal central bronchiectasis or
interstitial changes. Tuberculosis also was excluded after exam-
ining the Ziehl–Nielson staining of the bronchoalveolar ﬂuid.
Hypereosinophilic syndrome and Churg–Strauss syndrome have
many common features including neuropathy, rashes, and eosino-
philia; but asthma and elevated IgE levels, common to Churg–
Strauss syndrome, are rare in the hypereosinophilic syndrome and
were ruled out in our patient.3 Our patient had nasal polyposis,
which can accompany asthma and Churg–Strauss syndrome.
The diagnosis of Churg–Strauss syndrome can bemade based on
the presence of 4 or more of the following: asthma, peripheral
eosinophilia greater than 10%, peripheral neuropathy, transient or
migratory pulmonary opacities, paranasal sinus abnormality, and
extravascular eosinophils on biopsy.4 Our patient had nasal poly-
posis, asthma, peripheral eosinophilia, pulmonary consolidation in
the atelectatic regions, and diffuse eosinophilic inﬁltrates in the
bronchial biopsy sample; diagnosed as Churg–Strauss syndrome.
The term ANCA-associated vasculitis has been applied to small
vessel vasculitis, such as Wegener’s granulomatosis, microscopic
polyangiitis, and Churg–Strauss syndrome. The frequency of ANCA
in patients with Churg–Strauss syndrome is 50–78%.5 ANCA nega-
tivity, as in our patient, did not exclude the diagnosis.
Previous reports have suggested that the leukotriene receptor
antagonists used to treat asthma may cause Churg–Strauss
syndrome.6,7 Introducing these agents allows tapering of systemic
glucocorticoids and unmasking of a vasculitic syndrome in any
patient receiving a medication that suppresses asthmatic airway
Fig. 6. First month control thorax CT: Fibrotic sequel changes in middle lobe of right lung, and atelectasis improved.
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not use montelukast between the onset of asthma and vasculitis
(montelukast had been initiated in 2006, and her cerebrovascular
accident and myocardial infarction took place in 2001).
Radiologic pulmonary manifestations vary in Churg–Strauss
syndrome. The most common CT ﬁndings are areas of ground-glass
attenuation or consolidation in either a patchy or a predominantly
peripheral distribution. Less common abnormalities include small
centrilobular nodules, mediastinal lymphadenopathy, pericardial
effusion, and atelectasis.9 Previously, Silva and coworkers reviewed
the high-resolution CT and pathological ﬁndings in Churg–Strauss
syndrome of 7 patients.10 Only one patient had atelectasis and in
that patient, eosinophilic inﬁltration of airway walls was present as
in our patient; this might help to explain the lobar atelectasis.
Physicians should consider Churg–Strauss syndrome in young
patients presenting with asthma, nasal polyposis, cerebrovascular
accident, coronary artery disease, and lobar atelectasis.
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